Codes / ICD10CM / T45.515S

T45.515S Adverse effect of anticoagulants, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse Effect of Anticoagulants, Sequela
    • Also known as: Late effects of adverse drug reaction to blood thinners.

Summary

This condition describes residual or chronic effects resulting from a previous adverse reaction to anticoagulant medications. Anticoagulants, such as warfarin or heparin, are used to prevent blood clots but may cause long-term complications if initial adverse effects were not fully resolved.

Causes

Caused by the lingering effects of anticoagulant drugs, which can lead to persistent bleeding, tissue damage, or other sequelae following an initial adverse event. These effects may persist due to incomplete recovery, ongoing medication use, or irreversible damage from the original reaction.

Risk Factors

  • Prolonged or high-dose anticoagulant therapy.
  • Pre-existing conditions affecting healing (e.g., chronic kidney disease).
  • Delayed or inadequate treatment of the initial adverse event.
  • Advanced age or comorbidities impairing recovery.

Symptoms

  • Chronic bruising or discoloration at previous bleeding sites.
  • Persistent joint pain or swelling from hemarthrosis.
  • Recurrent minor bleeding episodes.
  • Fatigue or weakness from chronic blood loss.

Diagnosis

Diagnosis involves reviewing the patient's history of anticoagulant use and prior adverse events, conducting physical examinations to assess residual effects, and using lab tests (e.g., INR, imaging) to evaluate ongoing coagulation status or tissue damage.

Treatment Options

Treatment focuses on managing residual symptoms, such as pain relief for joint damage, monitoring for recurrent bleeding, and adjusting anticoagulant therapy if still required. Rehabilitation or surgical intervention may be necessary for severe sequelae.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial adverse event and the patient's overall health. Regular follow-up is essential to monitor for recurrence or new complications, with adjustments to care plans as needed.

Complications

  • Chronic anemia from persistent bleeding.
  • Joint degeneration or mobility issues.
  • Increased risk of future bleeding events.
  • Psychological impact from prolonged recovery.

Lifestyle & Prevention

  • Avoid activities with high injury risk if bleeding susceptibility remains.
  • Maintain regular lab monitoring if anticoagulants are continued.
  • Follow-up with healthcare providers to address residual symptoms promptly.

When to Seek Professional Help

Seek care if new or worsening bleeding occurs, if pain or swelling persists, or if signs of anemia (e.g., dizziness, fatigue) develop. Immediate attention is needed for severe or uncontrolled bleeding.

Tips for Medical Coders

Document the nature of the sequela (e.g., chronic joint damage, persistent anemia) and its relationship to the prior anticoagulant adverse effect. Include details on current management and any ongoing monitoring to support code assignment.

Book a walkthrough

T45.515S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.